Rice Biotech Launch Pad startup Motif Neurotech closes Series A financing of $18.75 million
Funding to develop miniature implantable stimulator to unlock minimally invasive therapies for treatment-resistant neuropsychiatric disorders.
HOUSTON – (Jan. 24, 2023) – Rice University today announced that Motif Neurotech, a neurotechnology company developing minimally invasive bioelectronics for mental health formed through the Rice Biotech Launch Pad, closed an oversubscribed Series A financing round of $18.75 million.
Read more here.
Comments